Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001047469-09-000782
Filing Date
2009-02-06
Accepted
2009-02-06 15:20:24
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B2 a2190348z424b2.htm 424B2 345308
2 G1021248.JPG g1021248.jpg GRAPHIC 5299
3 G79627.JPG g79627.jpg GRAPHIC 9758
4 G13835.JPG g13835.jpg GRAPHIC 13892
  Complete submission text file 0001047469-09-000782.txt   387975
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-153696 | Film No.: 09576945
SIC: 2834 Pharmaceutical Preparations

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filer) CIK: 0001443411 (see all company filings)

EIN.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-153696-03 | Film No.: 09576944

Mailing Address P.O.BOX HM 2899 HAMILTON D0 HM LX
Business Address 131 FRONT STREET HAMILTON D0 HM 12 (1)441 296 8025
Novartis Securities Investment Ltd. (Filer) CIK: 0001443663 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-153696-02 | Film No.: 09576943